BridgeMD
New treatment option for Cough
Official title Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects?
ClinicalTrials.gov ID: NCT06190431
What this study is testing
- What it's testing
- The use of mechanical insufflation-exsufflation (MI-E) in children with neuromuscular diseases (NMD) is recommended by international guidelines and societies and well documented. Many authors have shown that MI-E is safe and effective for airway clearance and has a significant benefit in reducing the duration of the airway clearance session in children with respiratory infections and atelectasis or in the postoperative period.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12. Healthy volunteers may be eligible.
You may be able to join if
- Part 1:
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
- Speak and understand French
You likely can't join if
- Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
- History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity. Part 2:
- Inclusion criteria
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
See the full eligibility criteria
- Part 1:
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
- Speak and understand French
- Schooling in mainstream education
- Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
- History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity. Part 2:
- Inclusion criteria
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
- Speak and understand French
- Patient with a neuromuscular disease
- Able to perform the MI-E maneuver
- Exclusion criteria
- Hemodynamic instability
- Current or recent pneumothorax
- Hemoptysis
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Brussels Capital, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Brussels Capital, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.